Savient Pharmaceuticals Announces Abstract Related To ...

Wall Street JournalSavient's abstract, #FR-PO417, entitled "Pegloticase, a Recombinant Uricase for the Treatment of Advanced Gout, Maintains Therapeutic Concentrations During...

Read More >>> See all stories on this topic »